Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Mycobacterium tuberculosis ESAT6 CFP10 antigen - AnHui Longcom Biologic Pharmacy

Next Previous
Drug Profile

Mycobacterium tuberculosis ESAT6 CFP10 antigen - AnHui Longcom Biologic Pharmacy

Alternative Names: AEC / BC02; ESAT6-CFP10; Mycobacterium riyadhense vaccine - AnHui Longcom Biologic Pharmacy; Recombinant EC allergen

Latest Information Update: 14 May 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator AnHui Longcom Biologic Pharmacy
  • Class Antibody diagnostics; Proteins; Synthetic vaccines; Tuberculosis vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Tuberculosis

Most Recent Events

  • 22 Sep 2025 Anhui Zhifei Longcom Biologic Pharmacy completes a phase III trial for Tuberculosis (In the elderly) in China (Intradermal, Injection) (NCT05899179)
  • 28 Nov 2023 Anhui Zhifei Longcom Biologic Pharmacy suspends a phase-II trial in Tuberculosis (Prevention) in China (IM) (NCT05284812)
  • 16 Jun 2023 Anhui Zhifei Longcom Biologic Pharmacy plans a phase III trial in Tuberculosis (In the elderly) [Intradermal,Injection] in June 2023 (NCT05899179)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top